Haider Shamsulddin
Internal Medicine · Lexington, KYNPI 1528366457
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $250 of the $405 with a category attached, or 61.8%. Ambu A/s accounts for 61.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $250 and has fallen 90.0% since, to $25 in 2025. That places this record below the midpoint for internal medicine clinicians in KY, where the typical reported total is $349.
Across 9 payments — averaging $44.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ambu A/s$250
- Novartis$36
- AbbVie$35
- BD$25
- Genentech USA, Inc.$25
- Tetraphase Pharmaceuticals, Inc.$20
- plus $14 from 1 others
What the payments were for
- Consulting fees$25062%
- Speaking & faculty fees$256%
- Food & beverage$13032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ambu A/s | 1 | $250 |
| Novartis | 2 | $36 |
| AbbVie | 2 | $35 |
| BD | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca | 1 | $14 |
How this compares
$405 in reported general payments places this provider in the 50th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $580 |
| Cefdinir | 43 | $324 |
| Atorvastatin Calcium | 28 | $171 |
| CefuroximeCefuroxime Axetil | 11 | $168 |
| Methylprednisolone | 24 | $126 |
| Carvedilol | 20 | $101 |
| Doxycycline Hyclate | 24 | $90 |
| Pantoprazole Sodium | 15 | $79 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $69 |
| Amlodipine Besylate | 21 | $45 |
| Furosemide | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lexington
- David ManninoLexington$168K
- Fadi BachaLexington$31K
- Jad BalloutLexington$30K
- Thomas von UnrugLexington$22K
- Danilo CoralesLexington$17K
- Mohamed TashaniLexington$17K
- Kelli TrentLexington$16K
- Richard BeltLexington$14K
- Coutney SchniedersLexington$12K
- Fares KhaterWhitesburg$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.